AUGUGLIARO, MATTEO
 Distribuzione geografica
Continente #
EU - Europa 2.156
AS - Asia 1.547
NA - Nord America 1.546
SA - Sud America 132
AF - Africa 52
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.443
Nazione #
US - Stati Uniti d'America 1.492
DE - Germania 1.189
SG - Singapore 459
CN - Cina 444
IT - Italia 327
HK - Hong Kong 162
VN - Vietnam 144
SE - Svezia 133
RU - Federazione Russa 112
BR - Brasile 102
BD - Bangladesh 100
GB - Regno Unito 93
FR - Francia 72
IN - India 64
NL - Olanda 51
IE - Irlanda 41
JP - Giappone 37
FI - Finlandia 36
CA - Canada 33
ID - Indonesia 29
PH - Filippine 28
CI - Costa d'Avorio 26
TR - Turchia 21
DK - Danimarca 16
AT - Austria 15
BE - Belgio 13
KR - Corea 13
AR - Argentina 10
AU - Australia 8
CH - Svizzera 8
ES - Italia 8
MX - Messico 8
PL - Polonia 8
CL - Cile 6
UA - Ucraina 6
ZA - Sudafrica 6
IQ - Iraq 5
KE - Kenya 5
PK - Pakistan 5
CR - Costa Rica 4
HU - Ungheria 4
IR - Iran 4
MY - Malesia 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
AZ - Azerbaigian 3
BO - Bolivia 3
EC - Ecuador 3
EG - Egitto 3
LU - Lussemburgo 3
MA - Marocco 3
RO - Romania 3
TW - Taiwan 3
AO - Angola 2
CO - Colombia 2
DO - Repubblica Dominicana 2
EU - Europa 2
GE - Georgia 2
JO - Giordania 2
KZ - Kazakistan 2
MK - Macedonia 2
PE - Perù 2
PY - Paraguay 2
VE - Venezuela 2
AF - Afghanistan, Repubblica islamica di 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
GI - Gibilterra 1
GR - Grecia 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MD - Moldavia 1
MO - Macao, regione amministrativa speciale della Cina 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
ST - Sao Tome e Principe 1
SV - El Salvador 1
Totale 5.439
Città #
Frankfurt am Main 1.102
Singapore 281
Ashburn 237
Chandler 170
Hong Kong 147
San Jose 118
Milan 104
Beijing 91
Dallas 65
New York 63
Southend 57
Council Bluffs 54
Los Angeles 52
Princeton 46
Ho Chi Minh City 45
Santa Clara 41
Dublin 39
Fairfield 37
Cambridge 31
Helsinki 30
Jakarta 29
Wilmington 29
Hanoi 27
Abidjan 26
Houston 26
Buffalo 25
Phoenix 25
Munich 23
Seattle 23
Tokyo 23
Guangzhou 22
Lauterbourg 22
Rome 21
Moscow 20
Hefei 18
Istanbul 18
Columbus 15
Shanghai 15
Woodbridge 15
Bengaluru 14
Hyderabad 14
Berlin 12
Des Moines 12
London 11
Toronto 11
Ann Arbor 10
Naples 10
Cangzhou 9
Haiphong 9
Jinan 9
Washington 9
Brussels 8
Da Nang 8
Flero 8
Medford 8
Menlo Park 8
Orem 8
Bologna 7
Dearborn 7
Düsseldorf 7
Mumbai 7
Denver 6
Florence 6
Montreal 6
Quanzhou 6
San Diego 6
Atlanta 5
Catania 5
Chengdu 5
Chicago 5
Fremont 5
Nuremberg 5
Paris 5
Silver Spring 5
Turin 5
Upper Marlboro 5
Verona 5
Warsaw 5
Wuhan 5
Yongin-si 5
Zurich 5
Boardman 4
Changsha 4
Dhaka 4
Duncan 4
Genoa 4
Hải Dương 4
Nairobi 4
Nanjing 4
Rio de Janeiro 4
Seoul 4
Shenyang 4
São Paulo 4
Vienna 4
Biên Hòa 3
Boston 3
Brescia 3
Budapest 3
Bühl 3
Cairo 3
Totale 3.613
Nome #
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): Potential of imaging and biology (AIRC IG-22159) 388
Machine Learning-Based Models for Prediction of Toxicity Outcomes in Radiotherapy 320
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 294
Oligorecurrent Prostate Cancer and Stereotactic Body Radiotherapy: Where Are We Now? A Systematic Review and Meta-analysis of Prospective Studies 290
Therapeutic Sequences in the Treatment of High-Risk Prostate Cancer: Paving the Way Towards Multimodal Tailored Approaches 248
Three weekly versus weekly concurrent cisplatin: safety propensity score analysis on 166 head and neck cancer patients 248
Exploring mirna signature and other potential biomarkers for oligometastatic prostate cancer characterization: The biological challenge behind clinical practice : a narrative review 241
Adjuvant radiotherapy in node positive prostate cancer patients: a debate still on. when, for whom? 233
Correlation between radiological and biological features and clinical outcomes in early prostate cancer: an exploratory subgroup analysis 233
Cytoreductive prostate radiotherapy in oligometastatic prostate cancer: A single centre analysis of toxicity and clinical outcome 226
Dosimetric Evaluation of the Inter-Fraction Motion of Organs at Risk in SBRT for Nodal Oligometastatic Prostate Cancer 218
High precision radiotherapy including intensitymodulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: A retrospective monoinstitutional study 206
Adjuvant high-dose-rate interstitial brachytherapy for malignant peripheral nerve sheath tumor of the foot: A case report 201
Finding safe dose-volume constraints for re-irradiation with SBRT of patients with prostate cancer relapse: The IEO experience 200
Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer 194
Carotid blowout syndrome after reirradiation for head and neck malignancies: a comprehensive systematic review for a pragmatic multidisciplinary approach 192
The T-N tract involvement as a new prognostic factor for PORT in locally advanced oral cavity tumors 192
IMRT versus 2D/3D conformal RT in oropharyngeal cancer: A review of the literature and meta-analysis 192
Mixed-beam approach for high-risk prostate cancer : Carbon-ion boost followed by photon intensity-modulated radiotherapy. Dosimetric and geometric evaluations (AIRC IG-14300) 182
Oligo metastatic renal cell carcinoma : stereotactic body radiation therapy, if, when and how? 178
Recurrent oligometastatic transitional cell bladder carcinoma: is there room for radiotherapy? 176
Salvage high-dose-rate interstitial brachytherapy for perineal recurrence of prostate cancer after surgery and radiotherapy : A case report 165
Re: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial 156
The impact of post-operative radiotherapy in early stage (Pt1-pT2N0M0) oral tongue squamous cell carcinoma in era of DOI 127
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719) 120
CyberKnife radiotherapy for orbital metastases : a single-center experience on 24 lesions 101
Stereotactic Body Radiation Therapy and Abiraterone Acetate for Patients Affected by Oligometastatic Castrate-Resistant Prostate Cancer: A Randomized Phase II Trial (ARTO) 74
null 5
Totale 5.600
Categoria #
all - tutte 15.377
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.377


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202121 0 0 0 0 0 0 0 0 0 0 11 10
2021/2022403 8 12 11 12 34 27 26 39 35 51 38 110
2022/2023543 69 74 50 40 51 79 14 48 58 3 39 18
2023/20241.046 13 21 39 20 84 46 173 133 72 126 163 156
2024/20251.185 160 147 133 125 81 50 23 64 63 89 108 142
2025/20262.041 221 161 170 176 193 120 359 66 173 135 267 0
Totale 5.600